A pharmacological analysis of the effects of (+)-AJ 76 and (+)-UH 232 at release regulating pre- and postsynaptic dopamine receptors.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  European Journal of Pharmacology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 8103459
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• (+)-UH 232 and (+)-UH 242: Novel stereoselective dopamine receptor antagonists with preferential action on autoreceptors

  2005cited by this paper
• A homologous series of N-alkylated cis-(+)-(1 S, 2 R)-5-methoxy-1-methyl-2-aminotetralins: Central dopamine receptor antagonists showing profiles ranging from classical antagonism to selectivity for autoreceptors

  2005cited by this paper
• Three classes of dopamine receptor (D-2, D-3, D-4) identified by binding studies with 3H-apomorphine and 3H-domperidone

  2004cited by this paper
• Effect of chronic cocaine treatment on D2 receptors regulating the release of dopamine and acetylcholine in the nucleus accumbens and striatum.

  1992cited by this paper
• Effects of repeated administration of the preferential dopamine autoreceptor antagonist, (+)-AJ76, on locomotor activity and brain DA metabolism in the rat.

  1991cited by this paper
• Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine

  1991cited by this paper
• D-2 dopamine autoreceptor selective drugs: do they really exist?

  1990cited by this paper
• Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

  1990cited by this paper
• Electrophysiological effects of dopamine autoreceptor antagonists, (+)-AJ 76 and (+)-UH 232.

  1990cited by this paper
• Increased dopamine release by the autoreceptor antagonist (+)-AJ 76 is Ca2(+)-dependent.

  1990cited by this paper
• (+)-AJ 76 and (+)-UH 232: Central stimulants acting as preferential dopamine autoreceptor antagonists

  1986cited by this paper
• Novel dopamine receptor agonists and antagonists with preferential action on autoreceptors.

  1985cited by this paper
• Evidence for autoreceptor modulation of endogenous dopamine release from rabbit caudate nucleus in vitro.

  1985cited by this paper
• Further functional in vitro comparison of pre- and postsynaptic dopamine receptors in the rabbit caudate nucleus

  1983cited by this paper
• Characterization of dopamine autoreceptor and [3H]spiperone binding sites in vitro with classical and novel dopamine receptor agonists.

  1983cited by this paper
• Are presynaptic dopamine autoreceptors and postsynaptic dopamine receptors in the rabbit caudate nucleus pharmacologically different?

  1982cited by this paper
• Anterior pituitary dopamine receptors. Demonstration of interconvertible high and low affinity states of the D-2 dopamine receptor.

  1982cited by this paper
• Substituted benzamide drugs as selective neuroleptic agents.

  1981cited by this paper
• Dopamine auto- and postsynaptic receptors: electrophysiological evidence for differential sensitivity to dopamine agonists.

  1979cited by this paper
• Metabolism and efflux of [3H]dopamine in rat neostriatum: presynaptic origin of 3,4-[3H]dihydroxyphenylacetic acid.

  1979cited by this paper
• Dopamine receptors localised on cerebral cortical afferents to rat corpus striatum

  1978cited by this paper
• Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity.

  1977cited by this paper
• Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs.

  1976cited by this paper
• Antipsychotic drug doses and neuroleptic/dopamine receptors

  1976cited by this paper
• THE RELEASE OF LABELLED ACETYLCHOLINE AND CHOLINE FROM CEREBRAL CORTICAL SLICES STIMULATED ELECTRICALLY

  1974cited by this paper
• Multiple regression in psychological research and practice.

  1968cited by this paper

• Prenatal cocaine exposure decreases nigrostriatal dopamine release in vitro: Effects of age and sex

  2004cites this paper
• [Arterial chemoreceptors: cellular and molecular mechanisms in the adaptative and homeostatic function of the carotid body].

  2003cites this paper
• Neurochemical and behavioral evidence supporting (+)-AJ 76 as a potential pharmacotherapy for cocaine abuse

  1998cites this paper
• Compensatory sleep responses to wakefulness induced by the dopamine autoreceptor antagonist (-)DS121.

  1998cites this paper
• 3-[[(4-Aryl-1-piperazinyl)alkyl]cyclohexyl]-1H-indoles as dopamine D2 partial agonists and autoreceptor agonists.

  1997cites this paper
• Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity.

  1997cites this paper
• Effects of intrastriatal infusion of D2 receptor antisense oligonucleotide on apomorphine‐induced behaviors in the rat

  1997cites this paper
• Dopamine D2 receptors in signal transduction and behavior.

  1997cites this paper
• The involvement of dopamine D2 receptors, but not D3 or D4 receptors, in the rewarding effect of brain stimulation in the rat.

  1997cites this paper
• Aminotetralin drugs and D3 receptor functions. What may partially selective D3 receptor ligands tell us about dopamine D3 receptor functions?

  1996cites this paper
• Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways.

  1995cites this paper
• Effect of (−)-DS 121 and (+)-UH 232 on cocaine self-administration in rats

  1995cites this paper
• Intranigral administration of D2 dopamine receptor antisense oligodeoxynucleotides establishes a role for nigrostriatal D2 autoreceptors in the motor actions of cocaine.

  1994cites this paper
• Intracerebral infusion of (+)-AJ76 and (+)-UH232: effects on dopamine release and metabolism in vivo.

  1994cites this paper